One-visit specialist team for atypical parkinsonian disorders
Part of Brain & nervous system clinical trials.
This study tests whether a single visit with a team of specialists can better support people with atypical parkinsonian disorders (like MSA, PSP, or CBS). The goal is to improve care planning and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 40 years.
- You have a clinical diagnosis of one of these conditions: multiple system atrophy (MSA), progressive supranuclear palsy (PSP), or corticobasal syndrome (CBS).
- You are able to come to the clinic in person.
- You do not have severe, life-threatening medical conditions (like advanced kidney disease on dialysis, severe heart failure, or advanced cancer).
- You live at home with a care partner (not in a long-term care facility).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with certain rare brain conditions that affect movement and thinking, such as multiple system atrophy, dementia with Lewy bodies, progressive supranuclear palsy, and corticobasal degeneration. It aims to learn more about how these conditions progress over time, which may help improve future care.
This trial tests whether a supplement called nicotinamide riboside (NR) can help people with rare forms of parkinsonism (PSP, MSA, or CBS). It is a double-blind study, meaning neither you nor the doctors will know if you are getting the real supplement or a placebo.
This study looks at genetic factors in people with PSP, CBS, MSA, or similar brain conditions, and also in their family members. It involves genetic testing to learn more about these diseases and may help find new treatments.
This study tests whether “Parkinson specialized teams” can improve care for people with Parkinson’s disease who live at home, with help from a main family caregiver. It looks at whether specialized support can be followed over time and whether it helps daily functioning.
This study compares different ways of targeting treatment for Parkinson's disease symptoms. It is designed for people with mild to moderate Parkinson's who have had symptoms for at least 2 years and are generally stable on their current medications.
This study looks at how people with certain rare brain conditions (like progressive supranuclear palsy, corticobasal syndrome, or multiple system atrophy) use healthcare services and how their quality of life is affected. It may help doctors better support patients and their carers.
Hear when a new Parkinson Plus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.